Stock 002880 SHENZHEN WEIGUANG BIOLOGICAL PRODUCTS CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Company Shenzhen Weiguang Biological Products Co., Ltd.

Equities

002880

CNE100002Q58

Pharmaceuticals

End-of-day quote Shenzhen S.E.
Other stock markets
 06:00:00 2024-05-22 pm EDT 		5-day change 1st Jan Change
29.92 CNY -1.22% Intraday chart for Shenzhen Weiguang Biological Products Co., Ltd. -2.06% -14.83%
2023 Weiguang Biological Products Gets Registration Certificate for Human Coagulation Factor VIII Drug MT
2023 Shenzhen Weiguang Biological Products Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023 CI

Business Summary

SHENZHEN WEIGUANG BIOLOGICAL PRODUCTS Co., Ltd. is a China-based high-tech company principally engaged in the research and development, production and sales of biological products. The Company’s primary products are blood products, including the human serum albumin, human immunoglobulin, intravenous human immunoglobulin, freeze-dried intravenous human immunoglobulin, hepatitis B human immunoglobulin, Rabies immunoglobulin, tetanus immunoglobulin, histamine human immunoglobulin, and human fibrinogen. The Company mainly operates its businesses in domestic market.

Number of employees: 796

Sales per Business

CNY in Million2022Weight2023Weight Delta
Human Albumin
37.9 %
257 38.5 % 398 37.9 % +54.52%
Intravenous Human Immunoglobulin Protein
35.8 %
239 35.8 % 375 35.8 % +56.76%
Rabies Immune Globulin
8.8 %
61 9.2 % 92 8.8 % +50.01%
Other Industries
6.1 %
14 2.1 % 63 6.1 % +353.54%
Tetanus Human Immunoglobulin
4.5 %
48 7.2 % 47 4.5 % -1.69%
Human Fibrinogen
4.5 %
- - 47 4.5 % -
Other Blood Products
2.5 %
48 7.2 % 26 2.5 % -44.83%

Sales per region

CNY in Million2022Weight2023Weight Delta
China
100.0 %
668 100.0 % 1,049 100.0 % +56.98%

Managers

Managers TitleAgeSince
Cai Ping Guo CEO
 Chief Executive Officer 53 93-12-31
Zhan Zhang CHM
 Chairman 52 94-06-30
Sen Cai BRD
 Director/Board Member 46 10-02-28
Li Jun Wei IRC
 Investor Relations Contact - -
Qiang Xu PRN
 Corporate Officer/Principal 60 02-01-31
Xin Zhang SEC
 Corporate Secretary 62 00-03-31

Members of the board

Members of the board TitleAgeSince
Ji Jiang Lin BRD
 Director/Board Member 48 -
Shu Ying Sun BRD
 Director/Board Member 51 -
Lu Zhang BRD
 Director/Board Member 52 -
Sen Cai BRD
 Director/Board Member 46 10-02-28
Xun He BRD
 Director/Board Member 60 19-01-03
Zhan Zhang CHM
 Chairman 52 94-06-30
Xin Min Wang BRD
 Director/Board Member 55 -
Xin Fa Yang BRD
 Director/Board Member 55 -
Peng Geng BRD
 Director/Board Member 41 19-01-03
Cai Ping Guo CEO
 Chief Executive Officer 53 93-12-31

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 226,800,000 50,431,610 ( 22.24 %) 0 22.24 %

Shareholders

NameEquities%Valuation
Shenzhen Guangming State-Owned Asset & Supervision & Admin Bur
65.25 %
147,987,000 65.25 % 614 M ¥
China State-Owned Assets Supervision & Admn Commission
7.250 %
16,443,000 7.250 % 68 M ¥
Guangzhou Jiahe Biotechnology Co. Ltd.
1.722 %
3,905,566 1.722 % 16 M ¥
ICBC Credit Suisse Asset Management Co., Ltd.
1.694 %
3,842,060 1.694 % 16 M ¥
Man Li
1.474 %
3,343,200 1.474 % 14 M ¥
Xue Song Zhu
1.119 %
2,537,472 1.119 % 11 M ¥
Jie He
0.6393 %
1,450,000 0.6393 % 6 M ¥
Lin Li
0.6066 %
1,375,701 0.6066 % 6 M ¥
Shenzhen Weiguang Biological Products Co. Ltd. ESOP
0.5373 %
1,218,630 0.5373 % 5 M ¥
Bank of Communications Schroder Fund Management Co., Ltd.
0.4037 %
915,680 0.4037 % 4 M ¥

Company contact information

Shenzhen Weiguang Biological Products Co., Ltd.

Guangming Street 3402 Guangqiao Avenue

518107, Shenzhen

+

http://www.szwg.com
address Shenzhen Weiguang Biological Products Co., Ltd.(002880)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Biopharmaceuticals

Sales per Business

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
29.92 CNY
Average target price
36 CNY
Spread / Average Target
+20.32%
Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Biopharmaceuticals

1st Jan change Capi.
SHENZHEN WEIGUANG BIOLOGICAL PRODUCTS CO., LTD. Stock Shenzhen Weiguang Biological Products Co., Ltd.
-14.83% 937M
CSL LIMITED Stock CSL Limited
-2.00% 90.27B
SAMSUNG BIOLOGICS CO.,LTD. Stock Samsung Biologics Co.,Ltd.
+1.32% 40.12B
BIOGEN INC. Stock Biogen Inc.
-16.01% 31.75B
UCB Stock UCB
+62.55% 26.6B
BIOMARIN PHARMACEUTICAL INC. Stock BioMarin Pharmaceutical Inc.
-21.50% 14.41B
INCYTE CORPORATION Stock Incyte Corporation
-8.62% 12.92B
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD. Stock Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
-13.06% 11.44B
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD. Stock Chongqing Zhifei Biological Products Co., Ltd.
-44.07% 11.3B
SWEDISH ORPHAN BIOVITRUM AB Stock Swedish Orphan Biovitrum AB
+4.87% 8.87B
Biopharmaceuticals
  1. Stock Market
  2. Equities
  3. 002880 Stock
  4. Company Shenzhen Weiguang Biological Products Co., Ltd.